Cancer Clinical Trials in Lexington, Kentucky

4 studies are recruiting for cancer in Lexington, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Abatacept in Immune Checkpoint Inhibitor Myocarditis

    The primary aim is to test whether abatacept, as compared to placebo, is associated with a reduction in major adverse cardiac events (MACE) among participants hospitalized with myocarditis secondary to an immune checkpoint inhibitor (ICI). The primary outcome, MACE, is a composite of first occurren…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Kentucky, Lexington, Kentucky
    Locations
    31 in total
    Run by
    Massachusetts General Hospital

    See if you can join NCT05335928 on ClinicalTrials.gov

  2. Impact of Daily Oral Cannabis Doses in Patients With Cancer

    This study will enroll patients with cancer and participants will be randomized to receive one dose of cannabis for approximately 4 months. There is a 3/4 (or 75%) chance that a participant will receive an active cannabis dose in the study. There is a 1/4 (or 25% chance) that a participant will rec…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Kentucky, Lexington, Kentucky
    Run by
    Shanna Babalonis, PhD

    See if you can join NCT06601218 on ClinicalTrials.gov

  3. Comprehensive Connected Cancer Care (C4): Intervention Evaluation

    The C4 program aims to provide a multi-level intervention program (Patient Level, Healthcare Team and Healthcare System Level) that improves the coordination of care with supportive/ancillary care providers and community services through the use of patient navigation and a digital needs assessment …

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Kentucky, Lexington, Kentucky
    Run by
    Timothy Mullett

    See if you can join NCT06326567 on ClinicalTrials.gov

  4. Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies

    This is a substudy (Part 2) of a larger two-part clinical trial including both observational and therapeutic (interventional) cohorts to assess the progression free survival ratio of patients treated with a targeted therapy based on genomic analysis results and recommendation by the Markey Cancer C…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Markey Cancer Center, University of Kentucky, Lexington, Kentucky
    Run by
    Rachel Miller

    See if you can join NCT03089554 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.